Enveric Biosciences
ENVB
ENVB
22 hedge funds and large institutions have $4.64M invested in Enveric Biosciences in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 0.01% → 0.01% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Holders
22
Holding in Top 10
–
Calls
$740K
Puts
$109K
Top Buyers
| 1 | +$1.02M | |
| 2 | +$650K | |
| 3 | +$195K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$153K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$110K |
Top Sellers
| 1 | -$89K | |
| 2 | -$52K | |
| 3 | -$18.6K | |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
-$17K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$14K |